首页> 外文期刊>World Allergy Organization Journal >Comparison of Effectiveness between Beclomethasone Dipropionate and Fluticasone Propionate in Treatment of Children with Moderate Asthma
【24h】

Comparison of Effectiveness between Beclomethasone Dipropionate and Fluticasone Propionate in Treatment of Children with Moderate Asthma

机译:丙酸倍氯米松和丙酸氟替卡松治疗小儿哮喘的疗效比较

获取原文
       

摘要

Asthma is a common chronic disease. Beclomethasone dipropionate (BDP) and Fluticasone propionate (FP) are 2 inhaled corticosteroids that frequently be used in treatment of patients with asthma. In this study, the effectiveness of BDP and FP in management of asthmatic children was investigated. In this trial, 50 children with moderate persistent asthma were randomly selected to receive either BDP 600 μg or FP 500 μg for 3 months. Pulmonary function tests were measured in both groups at the beginning of study and monthly after treatment. Daily and night symptoms and consistency of drugs were also measured. There was significantly better FEV1 in patients receiving FP compared with the BDP group (P P P = 0.001), while improvement of daily symptoms in this group compared with the BDP group was found from the second month (P = 0.001). Although symptoms and pulmonary function tests results were improved in both groups receiving either FP or BDP, this study suggested that FP was more effective than BDP in controlling moderate asthma in children.
机译:哮喘是一种常见的慢性疾病。丙酸倍氯米松(BDP)和丙酸氟替卡松(FP)是2种吸入的皮质类固醇,经常用于治疗哮喘患者。在这项研究中,研究了BDP和FP在哮喘儿童管理中的有效性。在该试验中,随机选择了50名患有中度持续性哮喘的儿童接受3个月BDP 600μg或FP 500μg。在研究开始时和治疗后每月对两组进行肺功能测试。还测量了日夜症状和药物的一致性。与BDP组相比,接受FP的患者的FEV1明显更好(P P P = 0.001),而从第二个月开始,与BDP组相比,该组的每日症状有所改善(P = 0.001)。尽管接受FP或BDP的两组的症状和肺功能测试结果均得到改善,但这项研究表明FP在控制儿童中度哮喘方面比BDP更有效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号